Trials / Completed
CompletedNCT03096808
Adaptive Radiotherapy for Head and Neck Cancer
A Prospective Non-Inferiority Trial of the Use of Adaptive Radiotherapy for Head and Neck Cancer Undergoing Radiation Therapy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate that adaptive radiotherapy (ART) in head and neck cancer patients are comparable to historical controls in head and neck patients undergoing standard intensity-modulated radiation therapy (IMRT) without ART.
Conditions
- Head and Neck Cancer
- Paranasal Sinus Cancer
- Oropharynx Cancer
- Oral Cavity Cancer
- Nasopharynx Cancer
- Larynx Cancer
- Hypopharynx Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Adaptive Radiotherapy | ART involved modification of the radiation treatment plan during treatment course to account for temporal variations in anatomy due to changes in tumor volume and/or patients' weight loss. |
Timeline
- Start date
- 2017-03-15
- Primary completion
- 2021-10-22
- Completion
- 2021-10-22
- First posted
- 2017-03-30
- Last updated
- 2021-10-26
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03096808. Inclusion in this directory is not an endorsement.